Replimune Group (REPL) Earnings Date & Reports

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

REPL is expected to report earnings to fall 14.51% to -64 cents per share on July 30

Replimune Group REPL Stock Earnings Reports

Q2'26

Est.

$-0.65

Q1'26

Missed

by $0.07

Q4'25

Missed

by $0.01

Q3'25

Missed

by $0.13

Q2'25

Missed

by $0.11

The last earnings report on June 29 showed earnings per share of -75 cents, missing the estimate of -68 cents. With 2.11M shares outstanding, the current market capitalization sits at 882.26M.

View a ticker or compare two or three

Compare

REPL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for REPL